Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.
Anderson School of Management, University of California, Los Angeles.
Elisa F
EF
Long
Division of Cancer Prevention and Control Research and Jonsson Comprehensive Cancer Center, University of California, Los Angeles3Fielding School of Public Health, University of California, Los Angeles.
Patricia A
PA
Ganz
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000235:genetics; D003362:Cost-Benefit Analysis; D003657:Decision Making; D055088:Early Detection of Cancer / Q000191:economics*; D019317:Evidence-Based Medicine; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D008327:Mammography / Q000191:economics; D009154:Mutation / Q000235:genetics; D019057:Quality-Adjusted Life Years; D014481:United States